{"data":[{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"Marc L. Andreessen","reportingCik":"0001160077","personType":"IN","sharesOwned":6263235,"percentOfClass":4.9,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"Benjamin A. Horowitz","reportingCik":"0001166586","personType":"IN","sharesOwned":6263235,"percentOfClass":4.9,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"AH Bio Fund II, L.P.","reportingCik":"0001725721","personType":"PN","sharesOwned":5782188,"percentOfClass":4.5,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"AH Equity Partners Bio II, L.L.C.","reportingCik":"0001725722","personType":"OO","sharesOwned":5782188,"percentOfClass":4.5,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"Andreessen Horowitz LSV Fund II, L.P.","reportingCik":"0001829357","personType":"PN","sharesOwned":481047,"percentOfClass":0.4,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001231919-26-001165","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-09","reportingPerson":"AH Equity Partners LSV II, L.L.C.","reportingCik":"0001829384","personType":"OO","sharesOwned":481047,"percentOfClass":0.4,"filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"Marc L. Andreessen","reportingCik":"0001160077","personType":"IN","sharesOwned":7684932,"percentOfClass":6,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"Benjamin A. Horowitz","reportingCik":"0001166586","personType":"IN","sharesOwned":7684932,"percentOfClass":6,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"AH Equity Partners Bio II, L.L.C.","reportingCik":"0001725722","personType":"OO","sharesOwned":7094691,"percentOfClass":5.6,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"AH Bio Fund II, L.P.","reportingCik":"0001725721","personType":"PN","sharesOwned":7094691,"percentOfClass":5.6,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"AH Equity Partners LSV II, L.L.C.","reportingCik":"0001829384","personType":"OO","sharesOwned":590241,"percentOfClass":0.5,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000006","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"Andreessen Horowitz LSV Fund II, L.P.","reportingCik":"0001829357","personType":"PN","sharesOwned":590241,"percentOfClass":0.5,"filedAt":"2026-08-28","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001193125-26-352644","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":"0001224962","personType":"IA","sharesOwned":11634211,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001193125-26-352644","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":"0001164426","personType":"IN","sharesOwned":11634211,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001193125-26-352644","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":"0001249675","personType":"CO","sharesOwned":11468351,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001193125-26-352644","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"C2 Life Sciences LLC","reportingCik":"0001890152","personType":"CO","sharesOwned":165860,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"Marc L. Andreessen","reportingCik":"0001160077","personType":"IN","sharesOwned":9063054,"percentOfClass":7.1,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"Benjamin A. Horowitz","reportingCik":"0001166586","personType":"IN","sharesOwned":9063054,"percentOfClass":7.1,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"AH Equity Partners Bio II, L.L.C.","reportingCik":"0001725722","personType":"OO","sharesOwned":8366966,"percentOfClass":6.6,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"AH Bio Fund II, L.P.","reportingCik":"0001725721","personType":"PN","sharesOwned":8366966,"percentOfClass":6.6,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"AH Equity Partners LSV II, L.L.C.","reportingCik":"0001829384","personType":"OO","sharesOwned":696088,"percentOfClass":0.5,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000004","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-26","reportingPerson":"Andreessen Horowitz LSV Fund II, L.P.","reportingCik":"0001829357","personType":"PN","sharesOwned":696088,"percentOfClass":0.5,"filedAt":"2026-06-30","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"Marc L. Andreessen","reportingCik":"0001160077","personType":"IN","sharesOwned":12653917,"percentOfClass":9.9,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"Benjamin A. Horowitz","reportingCik":"0001166586","personType":"IN","sharesOwned":12653917,"percentOfClass":9.9,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"AH Equity Partners Bio II, L.L.C.","reportingCik":"0001725722","personType":"OO","sharesOwned":11682032,"percentOfClass":9.2,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"AH Bio Fund II, L.P.","reportingCik":"0001725721","personType":"PN","sharesOwned":11682032,"percentOfClass":9.2,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"AH Equity Partners LSV II, L.L.C.","reportingCik":"0001829384","personType":"OO","sharesOwned":971885,"percentOfClass":0.8,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001725721-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":"63909J108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-02","reportingPerson":"Andreessen Horowitz LSV Fund II, L.P.","reportingCik":"0001829357","personType":"PN","sharesOwned":971885,"percentOfClass":0.8,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001857948-26-000003","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-02","reportingPerson":"Parag Mallick","reportingCik":"0001857948","personType":"IN","sharesOwned":22557411,"percentOfClass":17.6,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"},{"accessionNo":"0001378830-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001808805","issuerName":"Nautilus Biotechnology, Inc.","ticker":"NAUT","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-02","reportingPerson":"Sujal Patel","reportingCik":"0001378830","personType":"IN","sharesOwned":21249965,"percentOfClass":16.3,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/naut"}],"updatedAt":"2026-10-24T14:36:36.904Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/naut","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}